Invest in ME Research

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Invest in me.jpg

Invest in ME Research (Invest in ME or IIMER) is an independent UK charity founded by parents of patients, that campaigns for biomedical research into myalgic encephalomyelitis.[1] It is a supporter of the All-Party Parliamentary Group on Myalgic Encephalomyelitis but declined to join the UK CFS/ME Research Collaborative.[2]

Aims[edit | edit source]

Invest in ME Research provides funding, education and awareness of the disease.

International conferences[edit | edit source]

IiMER organizes and hosts hosts international colloquiums and conferences, see Invest in ME Conference.

Funding[edit | edit source]

Invest in ME Research do not receive any government funding. Let's do it for ME, a patient-run group, fundraises solely for Invest in ME Research.

Centre of Excellence for ME[edit | edit source]

Invest in ME Research is currently fundraising to establish an UK and Europe Centre of Excellence for ME.[3] The Let's C Research appeal supported by Let's Do It for ME is fundraising for centre of excellence.[4]

Notable people[edit | edit source]

Invest in ME Research Scientific Advisory Board[edit | edit source]

Studies funded[edit | edit source]

History[edit | edit source]

Online presence[edit | edit source]

Contact details[edit | edit source]

  • Address: PO Box 561, Eastleigh, Hampshire, SO50 0GQ
  • Phone: 02380 643736 / 07759 349743

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. Invest in ME - About us
  2. "Invest in ME Research - Redirect". www.investinme.org. Retrieved Aug 2, 2019. 
  3. Invest in ME Research. "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME". investinme.org. Retrieved Jan 28, 2019. 
  4. Let's Do It for ME. "Let's C Research | Read Fundraising's story". www.justgiving.com. Retrieved Jan 28, 2019. 
  5. Invest in ME Research. "Scientific Advisory Board". investinme.org. Retrieved Feb 15, 2019. 
  6. Mensah, Fane; Bansal, Amolak; Berkovitz, Saul; Sharma, Arti; Reddy, Venkat; Leandro, Maria; Cambridge, Geraldine (2016), "Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study", Clinical and Experimental Immunology, 184 (2): 237-247, doi:10.1111/cei.12749 
  7. Invest in ME Research. "Invest in ME Research - History". www.investinme.org. Retrieved Jan 28, 2019. 

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

B cell - B lymphocyte, or a type of white blood cell, which is involved in the immune response by secreting antibodies to ward off infections. In mammals, they are mostly matured in the bone marrow.

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.